Alembic Pharmaceuticals informs about outcome of board meeting

06 Dec 2018 Evaluate

Alembic Pharmaceuticals has informed that the Board of Directors of the company at its meeting held today has approved the Issue of Unsecured Listed Redeemable Non-Convertible Debentures (NCDs) of up to Rs 500 crores on Private Placement Basis under a shelf disclosure document in multiple tranches; and constituted NCD Committee for issue and allotment of NCDs. The time of commencement of the Board Meeting was 12:30 pm and the time of conclusion was 1:30 pm.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

762.55 -6.00 (-0.78%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×